Researchers conducted a target trial emulation to compare the effects of SGLT-2 inhibitor and DPP-4 inhibitor use on epilepsy among patients with type 2 diabetes.

Epilepsy in babies should not be underestimated. If seizures occur frequently and continuously, it can affect the growth and ...